| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9149(87)91081-2 |
| P698 | PubMed publication ID | 3825930 |
| P2093 | author name string | Ryan TJ | |
| Fisher LD | |||
| Chaitman BR | |||
| Weiner DA | |||
| McCabe CH | |||
| Luk S | |||
| Sheffield LT | |||
| Tristani F | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | silent myocardial ischemia | Q16644072 |
| P304 | page(s) | 725-729 | |
| P577 | publication date | 1987-04-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease | |
| P478 | volume | 59 |
| Q77766373 | ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Ang |
| Q36832309 | Acute heavy alcohol intake increases silent myocardial ischaemia in patients with stable angina pectoris |
| Q73227454 | Anginal status and prediction of cardiac events in patients enrolled in the asymptomatic cardiac ischemia pilot (ACIP) study. ACIP investigators |
| Q37291498 | Asymptomatic ST-segment depression during exercise testing and the risk of sudden cardiac death in middle-aged men: a population-based follow-up study |
| Q77169929 | Attenuation of ischemia-induced activation of cardiac sympathetic afferents following brief myocardial ischemia in cats |
| Q73199248 | Clinical implications of silent versus symptomatic exercise-induced myocardial ischemia in patients with stable coronary disease |
| Q68096439 | Comparison of coronary artery bypass surgery and medical therapy in patients with exercised-induced silent myocardial ischemia: a report from the Coronary Artery Surgery Study (CASS) registry |
| Q33545464 | Coronary heart disease. Stable and unstable syndromes |
| Q38578862 | Critical analysis of coronary artery bypass graft surgery: a 30-year journey |
| Q40513375 | Daily life cardiac ischaemia. Should it be treated? |
| Q33165286 | Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment |
| Q77616770 | Diabetes mellitus and cardiovascular disease |
| Q34733643 | Diagnosing coronary artery disease in diabetic patients |
| Q71495843 | Diagnosis of silent myocardial ischemia using ambulatory electrocardiographic monitoring with pedometer, analysis of heart rate, and ST loop in ambulatory electrocardiogram |
| Q50896664 | Differences between male and female patients with regard to baseline demographics and clinical outcomes in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Trial. |
| Q34839455 | Effects of carbon monoxide on myocardial ischemia |
| Q72180347 | Effects of nisoldipine in silent myocardial ischemia after healing of acute myocardial infarction |
| Q33971207 | Evaluating the cardiovascular tolerance for sex. |
| Q40697314 | Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men. |
| Q40801869 | Exercise-induced silent myocardial ischemia and future cardiac events in healthy, sedentary, middle-aged and older men. |
| Q68720866 | Exercise-induced silent myocardial ischemia: evaluation by thallium-201 emission computed tomography |
| Q33610541 | Identification of a high risk subgroup of patients with silent ischaemia after myocardial infarction: a group for early therapeutic revascularisation? |
| Q39612969 | Indications for treatment of silent myocardial ischemia |
| Q57013664 | Long-term prognosis of painless exercise-induced ischemia in stable patients with previous myocardial infarction |
| Q68060391 | Long-term variation in myocardial ischemia during daily life in patients with stable coronary artery disease: its relation to changes in the ischemic threshold |
| Q33843607 | Modification of high blood pressure after myocardial infarction |
| Q68297577 | Myocardial Ischemia in Coronary Disease |
| Q71017716 | North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management angina. North of England Stable Angina Guideline Development Group |
| Q38811072 | Overview of Management of Myocardial Ischemia: a Mechanistic-Based Approach |
| Q67921183 | Prevalence and prognostic significance of silent and symptomatic ischemia after coronary bypass surgery: A report from the Coronary Artery Surgery Study (CASS) randomized population |
| Q72220508 | Prevalence, characteristics, and risk stratification of electrocardiographic and symptomatic silence of myocardial ischemia despite scintigraphically evidenced ischemia in symptomatic patients presenting with severe coronary artery stenosis |
| Q73943096 | Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study) |
| Q47338501 | Prognostic significance of silent ischemia |
| Q77542169 | Should only the squeaky wheel get the grease? The prognostic significance of silent ischemia detected by exercise treadmill testing |
| Q46536656 | Silent ischemia after coronary angioplasty: evaluation of restenosis and extent of ischemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients |
| Q39607117 | Silent myocardial ischaemia |
| Q36676395 | Silent myocardial ischaemia. Implications for therapy |
| Q68497487 | Silent myocardial ischemia |
| Q33399462 | Silent myocardial ischemia is associated with altered plasma phospholipids |
| Q39533286 | Silent myocardial ischemia. Answers to frequently asked questions |
| Q70201757 | Silent myocardial ischemia: an update |
| Q39566662 | Silent myocardial ischemia: prognostic significance and therapeutic implications |
| Q36052982 | Silent myocardial ischemia: recent developments |
| Q38142756 | Stable angina pectoris: 2. Cardiac evaluation and diagnostic testing |
| Q71606958 | Susceptibility to pain during coronary angioplasty: usefulness of pulpal test |
| Q41757603 | Sustained reduction of exercise perfusion defect extent and severity with isosorbide mononitrate (Imdur) as demonstrated by means of technetium 99m sestamibi |
| Q39518710 | The frequency and significance of silent myocardial ischemia due to hyoscine butylbromide use in peripheral angiography. |
| Q67746687 | The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease |
| Q40915401 | The prognostic value of exercise testing. |
| Q33394008 | The role of coronary artery calcification score in clinical practice |
| Q37799015 | Total ischemic burden in patients with coronary artery disease |
| Q73660409 | [Ischemic sudden death: critical analysis of risk markers. Part VIII] |
Search more.